XB-ART-1815
Hum Mol Genet
2005 Jul 15;1414:2027-34. doi: 10.1093/hmg/ddi207.
Show Gene links
Show Anatomy links
AP-2alpha selectively regulates fragile X mental retardation-1 gene transcription during embryonic development.
???displayArticle.abstract???
Fragile X syndrome (FXS) is almost always caused by silencing of the FMR1 gene. The defects observed in FXS indicate that the normal FMR1 gene has a range of functions and plays a particularly prominent role during development. However, the mechanisms regulating FMR1 expression in vivo are not known. Here, we have tested the role of the transcription factor AP-2alpha in regulating Fmr1 expression. Chromatin immunoprecipitation showed that AP-2alpha associates with the Fmr1 promoter in vivo. Furthermore, Fmr1 transcript levels are reduced >4-fold in homozygous null AP-2alpha mutant mice at embryonic day 18.5 when compared with normal littermates. Notably, AP-2alpha exhibits a strong gene dosage effect, with heterozygous mice showing approximately 2-fold reduction in Fmr1 levels. Examination of conditional AP-2alpha mutant mice indicates that this transcription factor plays a major role in regulating Fmr1 expression in embryos, but not in adults. We further investigated the role of AP-2alpha in the developmental regulation of Fmr1 expression using the Xenopus animal cap assay. Over-expression of a dominant-negative AP-2alpha in Xenopus embryos led to reduced Fmr1 levels. Moreover, exogenous wild-type AP-2alpha rescued Fmr1 expression in embryos where endogenous AP-2alpha had been suppressed. We conclude that AP-2alpha associates with the Fmr1 promoter in vivo and selectively regulates Fmr1 transcription during embryonic development.
???displayArticle.pubmedLink??? 15930016
???displayArticle.link??? Hum Mol Genet
???displayArticle.grants???
Species referenced: Xenopus
Genes referenced: chrd fmr1 six3 tfap2a
???displayArticle.disOnts??? fragile X syndrome
???displayArticle.omims??? FRAGILE X SYNDROME; FXS
???attribute.lit??? ???displayArticles.show???